A recent Wall Street Journal article states pharmaceutical researchers are turning to technology to broaden access to experimental treatments, and make clinical trials more equitable in terms of their inclusion of minorities. Read how researchers like Elligo and Cerner Corporation are looking for new ways to make drug trials more diverse.